B. BRAUN BUYING DAVIS & GECK FROM AMERICAN CYANAMID
This article was originally published in The Gray Sheet
Executive Summary
B. BRAUN BUYING DAVIS & GECK FROM AMERICAN CYANAMID for an undisclosed amount under an agreement in principle announced July 8. Under the deal, B. Braun Melsungen AG would buy Cyanamid's worldwide wound management business, which includes surgical sutures and endoscopic products. Cyanamid and the German firm already have joint venture wound management companies in Germany, Portugal and Spain.